AstraZeneca Korea to hold five-finger heart campaign

Published: 2007-08-20 06:57:00

Updated: 2007-08-20 06:57:00

AstraZeneca Korea will hold its five-finger campaign to protect a heart for ordinary people and hypertensive patients to conduct an active publicity campaign of Atacand (candesartan).

AZ Korea said on August 16 that it offers various events so people visiting the events could also experience t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK